Michael Carolan

Chief Tech/Sci/R&D Officer at The Walter & Eliza Hall Institute of Medical Research

Consumer Services

Commercial Services

Profile

Michael Carolan is currently the Chief Information Officer at The Walter & Eliza Hall Institute of Medical Research.
He has a graduate degree and an MBA from The Open University, and an undergraduate degree from The University of Hull.

Michael Carolan active positions

Companies	Position	Start
The Walter & Eliza Hall Institute of Medical Research The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia.	Chief Tech/Sci/R&D Officer	-

All active positions of Michael Carolan

Training of Michael Carolan

The University of Hull	Undergraduate Degree
The Open University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Carolan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
The Walter & Eliza Hall Institute of Medical Research The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia.	Commercial Services